| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.0004 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |